Different susceptibility to peroxisome proliferator‐induced hepatocarcinogenesis in rats with polymorphic glutathione transferase genes

Although peroxisomal bifunctional enzyme (enoyl‐CoA hydratase/ l ‐3‐hydroxyacyl‐CoA dehydrogenase; BE) is a positive marker for peroxisome proliferation, it is completely absent or expressed very weakly in rat hepatic preneoplastic and neoplastic lesions induced by peroxisome proliferators (PP). After administration of PP for 8–15 weeks, some rats exhibit BE‐negative preneoplastic foci but other rats do not. In the present study, to investigate the involvement of glutathione S‐transferase ( GST ) M1 gene polymorphism in interindividual differences in susceptibility to PP, we developed a method to determine the genotypes of rats. We then examined whether rats with one type encoding 198 Asn‐ 199 Cys (NC‐type) or another encoding 198 Lys‐ 199 Ser (KS‐type) exhibit differences in clofibrate (CF) susceptibility. After administration of 0.3% CF for 6 weeks or more, BE‐negative foci were found immunohistochemically in KS/KS‐type rats, but not in NC/NC‐type rats. The number of BE‐negative foci in KS/KS rats was 15.3 ± 9.0 foci/cm 2 of liver section after 6 weeks of CF administration, and the values did not alter thereafter. The mean areas of BE‐negative foci in KS/KS rat livers increased during the period from 6 to 60 weeks. At weeks 30 and 60, almost all BE‐negative foci exhibited a clear cell phenotype, a type of preneoplastic hepatic lesion. BE‐negative foci were devoid of peroxisome proliferator‐activated receptor α, whereas surrounding tissues were positive for the receptor. These results indicate that rats that are polymorphic for the GST M1 gene exhibit different susceptibilities to CF in vivo . ( Cancer Sci 2006; 97: 703–709)